BioProcess360

Established in 2024, BioProcess360 is a venture capital firm headquartered in Delray Beach, Florida. It concentrates on investing in growth-stage companies within the biotechnology and life science sectors.

Chris Major

Founding Partner

2 past transactions

Abselion

Series A in 2024
Abselion develops biosensor technologies for rapid, cost-effective detection of biomolecules, including proteins, DNA, and small molecules. The company provides diagnostic analyzers and kits that simplify analysis of biomolecular interactions, supporting pharmaceutical research and manufacturing. Its platform enables sensitive, near real-time monitoring of interactions such as protein binding, helping researchers obtain timely data to inform experiments, diagnostics, and development pipelines.

IRUBIS

Seed Round in 2024
Founded in Munich, Germany in 2017, IRUBIS specializes in manufacturing Mid-Infrared (MIR) spectrometers and Attenuated Total Reflection (ATR) crystals. The company combines semiconductor technology with infrared spectroscopy to develop devices for analyzing protein-based drugs. IRUBIS offers a real-time bioprocess monitoring system using MIR spectroscopy, which measures glucose and lactate online without contamination risk. They also provide ATR crystals and accessory solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.